Laskey, R., Poniewierski, M., Lopez, M., Hanna, R., Alvarez-Secord, A., Gehrig, P., … Havrilesky, L. (2011). Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer. In Gynecologic Oncology (Vol. 120, pp. S74–S75). Elsevier BV. https://doi.org/10.1016/j.ygyno.2010.12.179

Laskey, R., M. Poniewierski, M. Lopez, R. Hanna, A. Alvarez-Secord, P. Gehrig, G. Lyman, and L. Havrilesky. “Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.” In Gynecologic Oncology, 120:S74–75. Elsevier BV, 2011. https://doi.org/10.1016/j.ygyno.2010.12.179.

Laskey R, Poniewierski M, Lopez M, Hanna R, Alvarez-Secord A, Gehrig P, et al. Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer. In: Gynecologic Oncology. Elsevier BV; 2011. p. S74–5.

Laskey, R., et al. “Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.” Gynecologic Oncology, vol. 120, Elsevier BV, 2011, pp. S74–75. Crossref, doi:10.1016/j.ygyno.2010.12.179.

Laskey R, Poniewierski M, Lopez M, Hanna R, Alvarez-Secord A, Gehrig P, Lyman G, Havrilesky L. Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer. Gynecologic Oncology. Elsevier BV; 2011. p. S74–S75.